Published in J Interv Card Electrophysiol on February 19, 2011
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study. Pacing Clin Electrophysiol (2014) 1.60
Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter. J Interv Card Electrophysiol (2013) 0.90
Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay. J Interv Card Electrophysiol (2013) 0.89
Rapid growth of left atrial myxoma after radiofrequency ablation. Tex Heart Inst J (2013) 0.86
Real-time ultrasound guidance reduces total and major vascular complications in patients undergoing pulmonary vein antral isolation on therapeutic warfarin. J Interv Card Electrophysiol (2013) 0.84
Safety and efficacy outcomes of protamine administration for heparin reversal following cryoballoon-based pulmonary vein isolation. J Interv Card Electrophysiol (2015) 0.78
Is dabigatran efficacy enough to prevent stroke in atrial fibrillation patient with high CHADS2 score during peri-procedural catheter radiofrequency ablation? A case report with literature review. Int J Clin Exp Med (2015) 0.77
Intramural Hematoma versus Thrombus: Radiation-induced Heart Disease Results in Mass Formation after Radiofrequency Ablation. Chin Med J (Engl) (2016) 0.75
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. J Arrhythm (2017) 0.75
[Catheter ablation of paroxysmal atrial fibrillation. Optimal approach and result]. Herzschrittmacherther Elektrophysiol (2013) 0.75
Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation (2005) 6.68
Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation (2007) 2.78
Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy. Heart Rhythm (2009) 2.34
Venice Chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol (2007) 2.25
Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern? J Cardiovasc Electrophysiol (2009) 2.12
Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation (2006) 1.74
Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2009) 1.74
Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function. Heart Rhythm (2005) 1.70
Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. J Cardiovasc Electrophysiol (2005) 1.46
Ultrasound-guided femoral dialysis access placement: a single-center randomized trial. Clin J Am Soc Nephrol (2009) 1.15
Atrial fibrillation ablation in patients with therapeutic international normalized ratios. Pacing Clin Electrophysiol (2009) 1.12
Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2009) 1.03
A randomized trial assessing the value of ultrasound-guided puncture of the femoral artery for interventional investigations. Int J Cardiovasc Imaging (2004) 0.94
Femoral vascular complications following catheter ablation of atrial fibrillation. J Interv Card Electrophysiol (2009) 0.82
Ultrasound-guided versus landmark-guided femoral vein access in pediatric cardiac catheterization. Pediatr Cardiol (2007) 0.82
Nonpharmacologic stroke prevention in atrial fibrillation. Expert Rev Cardiovasc Ther (2005) 0.80
Periprocedural anticoagulation for atrial fibrillation ablation. J Cardiovasc Electrophysiol (2008) 0.76
Ultrasound-guided compression of femoral artery pseudoaneurysm. J Ultrasound Med (1992) 0.75
Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol (2013) 5.67
Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med (2007) 5.05
Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med (2013) 3.76
Prospective study of sudden cardiac death among women in the United States. Circulation (2003) 3.45
Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator. Heart Rhythm (2007) 3.23
Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study. J Am Coll Cardiol (2007) 2.79
Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation (2007) 2.78
Multi-sensor esophageal temperature probe used during radiofrequency ablation for atrial fibrillation is associated with increased intraluminal temperature detection and increased risk of esophageal injury compared to single-sensor probe. J Cardiovasc Electrophysiol (2013) 2.65
Familial aggregation in lone atrial fibrillation. Hum Genet (2005) 2.55
Materials for multifunctional balloon catheters with capabilities in cardiac electrophysiological mapping and ablation therapy. Nat Mater (2011) 2.51
Importance of catheter contact force during irrigated radiofrequency ablation: evaluation in a porcine ex vivo model using a force-sensing catheter. J Cardiovasc Electrophysiol (2010) 2.47
Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation (2003) 2.42
Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation. Cardiovasc Res (2002) 2.29
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J (2009) 2.06
Drug-induced torsades de pointes and implications for drug development. J Cardiovasc Electrophysiol (2004) 2.05
Atrial fibrillation ablation using a robotic catheter remote control system: initial human experience and long-term follow-up results. J Am Coll Cardiol (2008) 2.02
Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies. Heart Rhythm (2008) 1.96
National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med (2004) 1.92
Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy. Heart Rhythm (2006) 1.87
Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol (2005) 1.78
Towards regenerative therapy for cardiac disease. Lancet (2012) 1.75
Esophageal injury and temperature monitoring during atrial fibrillation ablation. Circ Arrhythm Electrophysiol (2008) 1.75
Analysis of the left atrial appendage by magnetic resonance angiography in patients with atrial fibrillation. Heart Rhythm (2006) 1.75
Mortality of heart failure patients after cardiac resynchronization therapy: identification of predictors. J Cardiovasc Electrophysiol (2008) 1.69
Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm (2010) 1.66
Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace (2012) 1.64
Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience. Circ Arrhythm Electrophysiol (2014) 1.64
Role of implantable cardioverter-defibrillators in patients with methadone-induced long QT syndrome. Am J Cardiol (2008) 1.63
Intracardiac echocardiographic imaging of the left atrial appendage. Heart Rhythm (2005) 1.63
Use of intracardiac echocardiography to guide implantation of a left atrial appendage occlusion device (PLAATO). Heart Rhythm (2007) 1.61
Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial. Circ Arrhythm Electrophysiol (2014) 1.59
Ability of terminal QRS notching to distinguish benign from malignant electrocardiographic forms of early repolarization. Am J Cardiol (2009) 1.57
A proposal for new clinical concepts in the management of atrial fibrillation. Am Heart J (2012) 1.57
Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch Intern Med (2004) 1.55
Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol (2009) 1.54
Integration of cardiac CT/MR imaging with three-dimensional electroanatomical mapping to guide catheter manipulation in the left atrium: implications for catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 1.54
Inpatient vs. elective outpatient cardiac resynchronization therapy device implantation and long-term clinical outcome. Europace (2010) 1.53
Integration of cardiac magnetic resonance imaging with three-dimensional electroanatomic mapping to guide left ventricular catheter manipulation: feasibility in a porcine model of healed myocardial infarction. J Am Coll Cardiol (2004) 1.53
Timing of delayed perforation with the St. Jude Riata lead: a single-center experience and a review of the literature. Heart Rhythm (2008) 1.53
The esophageal effects of cryoenergy during cryoablation for atrial fibrillation. Heart Rhythm (2009) 1.52
Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol (2005) 1.50
Variability of coronary venous anatomy in patients undergoing cardiac resynchronization therapy: a high-speed rotational venography study. Heart Rhythm (2007) 1.50
Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm (2007) 1.50
Echocardiographic measures of acute haemodynamic response after cardiac resynchronization therapy predict long-term clinical outcome. Eur Heart J (2007) 1.48
Use of electrogram characteristics during sinus rhythm to delineate the endocardial scar in a porcine model of healed myocardial infarction. J Cardiovasc Electrophysiol (2003) 1.47
The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval. J Am Coll Cardiol (2005) 1.46
The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice. Eur Heart J (2004) 1.46
Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol (2005) 1.45
Electronic sensor and actuator webs for large-area complex geometry cardiac mapping and therapy. Proc Natl Acad Sci U S A (2012) 1.45
Short-term results of substrate mapping and radiofrequency ablation of ischemic ventricular tachycardia using a saline-irrigated catheter. J Am Coll Cardiol (2003) 1.43
Multiple ICD discharges associated with lead fracture without triggering of high impedance alert. Pacing Clin Electrophysiol (2009) 1.42
Is there an association between external cardioversions and long-term mortality and morbidity? Insights from the Atrial Fibrillation Follow-up Investigation of Rhythm Management study. Circ Arrhythm Electrophysiol (2011) 1.42
Amiodarone is poorly effective for the acute termination of ventricular tachycardia. Ann Emerg Med (2005) 1.40
The impact of respiration on left atrial and pulmonary venous anatomy: implications for image-guided intervention. Heart Rhythm (2005) 1.40
Unpredictable battery depletion of St Jude Atlas II and Atlas+ II HF implantable cardioverter-defibrillators. Heart Rhythm (2011) 1.38
The coronary venous anatomy: a segmental approach to aid cardiac resynchronization therapy. J Am Coll Cardiol (2005) 1.36
Remote magnetic navigation to guide endocardial and epicardial catheter mapping of scar-related ventricular tachycardia. Circulation (2007) 1.35
Pulmonary vein isolation using a visually guided laser balloon catheter: the first 200-patient multicenter clinical experience. Circ Arrhythm Electrophysiol (2013) 1.34
Relationship between catheter forces, lesion characteristics, "popping," and char formation: experience with robotic navigation system. J Cardiovasc Electrophysiol (2008) 1.34
Ablation of left ventricular epicardial outflow tract tachycardia from the distal great cardiac vein. J Am Coll Cardiol (2006) 1.31
Catheter ablation of ventricular epicardial tissue: a comparison of standard and cooled-tip radiofrequency energy. Circulation (2004) 1.30
Left atrial appendage dimensions predict the risk of stroke/TIA in patients with atrial fibrillation. J Cardiovasc Electrophysiol (2011) 1.27
Fiber architecture in remodeled myocardium revealed with a quantitative diffusion CMR tractography framework and histological validation. J Cardiovasc Magn Reson (2012) 1.26
Balloon catheter ablation to treat paroxysmal atrial fibrillation: what is the level of pulmonary venous isolation? Heart Rhythm (2007) 1.24
Relationship of the esophagus and aorta to the left atrium and pulmonary veins: implications for catheter ablation of atrial fibrillation. Heart Rhythm (2005) 1.23
Assessment of catheter tip contact force resulting in cardiac perforation in swine atria using force sensing technology. Circ Arrhythm Electrophysiol (2011) 1.20
Factors affecting error in integration of electroanatomic mapping with CT and MR imaging during catheter ablation of atrial fibrillation. J Interv Card Electrophysiol (2007) 1.17
Atrial fibrillation ablation strategies for paroxysmal patients: randomized comparison between different techniques. Circ Arrhythm Electrophysiol (2009) 1.16
Atrial tachycardia after ablation of persistent atrial fibrillation: identification of the critical isthmus with a combination of multielectrode activation mapping and targeted entrainment mapping. Circ Arrhythm Electrophysiol (2008) 1.14
Intraprocedural volume imaging of the left atrium and pulmonary veins with rotational X-ray angiography: implications for catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2007) 1.13
Clinical subtypes of lone atrial fibrillation. Pacing Clin Electrophysiol (2005) 1.12
Full-color direct visualization of the atrial septum to guide transseptal puncture. J Cardiovasc Electrophysiol (2008) 1.10
Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group. Circulation (2010) 1.07
What is the most appropriate energy source for aortic cusp ablation? A comparison of standard RF, cooled-tip RF and cryothermal ablation. J Interv Card Electrophysiol (2006) 1.07
Electrocardiographic characteristics in right ventricular vs biventricular pacing in patients with paced right bundle-branch block QRS pattern. J Electrocardiol (2011) 1.07
Drug-induced arrhythmia. Circulation (2010) 1.06
Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc. Am J Cardiol (2002) 1.06